Persistent interstitial pulmonary emphysema: another complication of the respiratory distress syndrome

Pediatrics
|June 1, 1977
PubMed

Insights

Persistent interstitial pulmonary emphysema (PIPE) in infants can be localized or diffuse. Localized PIPE showed better outcomes with surgical resection, while diffuse PIPE led to high mortality, often with bronchopulmonary dysplasia.

Area of Science:

  • Neonatal Medicine
  • Pediatric Pulmonology
  • Pathology

Background:

  • Persistent interstitial pulmonary emphysema (PIPE) is a rare neonatal respiratory condition.
  • Neonatal respiratory distress syndrome (RDS) is a common precursor, often treated with mechanical ventilation and oxygen therapy.

Purpose of the Study:

  • To describe the clinical presentation, management, and outcomes of persistent interstitial pulmonary emphysema (PIPE) in neonates.
  • To differentiate between localized and diffuse forms of PIPE and their associated prognoses.

Main Methods:

  • Retrospective review of 22 infants diagnosed with PIPE during the neonatal period.
  • Analysis of treatment strategies including artificial ventilation, oxygen therapy, and surgical resection.
  • Histological examination of lung tissue.

Main Results:

  • 21 of 22 infants received treatment for respiratory distress syndrome.
  • Ten infants had localized PIPE; 7 underwent successful lung resection, and 3 died.
  • Twelve infants had diffuse PIPE, with 11 developing bronchopulmonary dysplasia due to prolonged oxygen use; all 12 died.
  • Histology revealed air-filled interstitial cysts, sometimes lined by giant cells.

Conclusions:

  • Localized PIPE may be effectively treated with surgical resection, offering a survival advantage.
  • Diffuse PIPE carries a poor prognosis, frequently complicated by bronchopulmonary dysplasia and leading to mortality.
  • Histological features of interstitial cysts are characteristic of PIPE.

Related Concept Videos

Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Pulmonary Edema II: Pathophysiology01:18

Pulmonary Edema II: Pathophysiology

Pulmonary edema is the accumulation of fluid in the interstitial and alveolar spaces of the lungs, impairing gas exchange and oxygen delivery. It may be cardiogenic or noncardiogenic, but both reduce oxygenation and lung compliance.Cardiogenic Pulmonary EdemaCardiogenic edema results from increased hydrostatic pressure in pulmonary capillaries, usually due to left ventricular dysfunction from myocardial infarction, heart failure, or valvular disease. Ineffective cardiac pumping causes blood to...